PANDA Therapeutics secures €160K to advance multi-target Alzheimer’s therapy
Tech.eu Cate Lawrence
PANDA Therapeutics secured €160,000 from Venture Kick to move a multi-target Alzheimer’s therapy toward clinical development. The funding amount is €160,000 (CHF 150,000). It will be used for company formation and business development, including building advisory and CMC/manufacturing readiness plans, plus IP and regulatory planning for later financing and partnerships.
Why it matters
Biotech startup PANDA Therapeutics has obtained €160,000 (CHF 150,000) from Venture Kick to advance a new treatment for Alzheimer’s disease toward clinical development. By targeting multiple harmful p...
Related stories
AI drug discovery startup Basecamp Research raises $140M
SiliconANGLE · 3 weeks ago ·
26
Sightera Biosciences closes €3M pre-seed to expand its patient-derived AI drug discovery platform
Tech.eu · 3 months ago ·
11
Anthropic and Nvidia back Basecamp Research in $140M Series C
Tech.eu · 3 weeks ago ·
43
Sightera Biosciences closes €3M pre-seed to expand its patient-derived AI drug discovery platform
Tech.eu · 3 months ago ·
11
Anthropic and Nvidia back Basecamp Research in $140M Series C
Tech.eu · 3 weeks ago ·
43